| Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy L Palmerston Mendes, J Pan, VP Torchilin Molecules 22 (9), 1401, 2017 | 637 | 2017 |
| Recent advancements in liposome technology N Filipczak, J Pan, SSK Yalamarty, VP Torchilin Advanced drug delivery reviews 156, 4-22, 2020 | 358 | 2020 |
| Micelle-like nanoparticles as carriers for DNA and siRNA G Navarro, J Pan, VP Torchilin Molecular pharmaceutics 12 (2), 301-313, 2015 | 122 | 2015 |
| Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin MM Khan, A Madni, V Torchilin, N Filipczak, J Pan, N Tahir, H Shah Drug delivery 26 (1), 765-772, 2019 | 114 | 2019 |
| Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance J Pan, LP Mendes, M Yao, N Filipczak, S Garai, GA Thakur, C Sarisozen, ... European Journal of Pharmaceutics and Biopharmaceutics 136, 18-28, 2019 | 95 | 2019 |
| Polymeric co-delivery systems in cancer treatment: an overview on component drugs’ dosage ratio effect J Pan, K Rostamizadeh, N Filipczak, VP Torchilin Molecules 24 (6), 1035, 2019 | 80 | 2019 |
| Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR … SK Sriraman, J Pan, C Sarisozen, E Luther, V Torchilin Molecular pharmaceutics 13 (2), 428-437, 2016 | 56 | 2016 |
| Polymers in the co-delivery of siRNA and anticancer drugs to treat multidrug-resistant tumors C Sarisozen, J Pan, I Dutta, VP Torchilin Journal of pharmaceutical investigation 47, 37-49, 2017 | 49 | 2017 |
| Surface-engineered polyethyleneimine-modified liposomes as novel carrier of siRNA and chemotherapeutics for combination treatment of drug-resistant cancers LP Mendes, C Sarisozen, E Luther, J Pan, VP Torchilin Drug delivery 26 (1), 443-458, 2019 | 44 | 2019 |
| Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy MM Khan, A Madni, N Filipczak, J Pan, M Rehman, N Rai, SA Attia, ... Nanomedicine: Nanotechnology, Biology and Medicine 28, 102228, 2020 | 40 | 2020 |
| Charge reversible hyaluronic acid-modified dendrimer-based nanoparticles for siMDR-1 and doxorubicin co-delivery X Zhang, J Pan, M Yao, LP Mendes, C Sarisozen, S Mao, VP Torchilin European Journal of Pharmaceutics and Biopharmaceutics 154, 43-49, 2020 | 36 | 2020 |
| Monoclonal antibody 2C5-modified mixed dendrimer micelles for tumor-targeted codelivery of chemotherapeutics and siRNA J Pan, SA Attia, MA Subhan, N Filipczak, LP Mendes, X Li, ... Molecular Pharmaceutics 17 (5), 1638-1647, 2020 | 30 | 2020 |
| Dendrimers for drug delivery purposes J Pan, SA Attia, N Filipczak, VP Torchilin Nanoengineered Biomaterials for Advanced Drug Delivery, 201-242, 2020 | 10 | 2020 |
| Applications of quantitative time lapse holographic imaging to the development of complex pharmaceutical nano formulations E Luther, L Mendes, J Pan, D Costa, C Sarisozen, V Torchilin Quantitative Phase Imaging IV 10503, 190-207, 2018 | 1 | 2018 |
| Bouvé College of Health Sciences J Pan NORTHEASTERN UNIVERSITY BOSTON, 2020 | | 2020 |
| Chemo-Resistance Reversal Using Nanomedicines C Sarisozen, J Pan, VP Torchilin Molecular Medicines for Cancer, 91-136, 2018 | | 2018 |
| Development of methodologies for high content, label free time lapse monitoring of the effects of “smart” nano-particle formulations, using Kolmogorov-Smirnov based multiple … E Luther, LP Mendes, J Pan, D Costa, C Sarisozen, VP Torchilin 2017 Controlled Release Society Annual Meeting, 2017 | | 2017 |
| Polyethylenimine-coated liposomes for the delivery of nucleic acid/drug combination: overcoming multidrug resistance in cancer therapy LP Mendes, J Pan, C Sarisozen, VP Torchilin 2017 Controlled Release Society Annual Meeting, 2017 | | 2017 |
| G4-polyamido-amine dendrimer-based nanopreparation for co-delivery of chemotherapy and siRNA J Pan, LP Mendes, C Sarisozen, VP Torchilin 2017 Controlled Release Society Annual Meeting, 2017 | | 2017 |
| Development of a 4-sample version of the Kolmogorov–Smirnov test for evaluating the temporal physiology of cells treated with test compounds in a label-free, high content … E Luther, L Mendes, J Pan, D Costa, E Holden, V Torchilin Cancer Research 77, 2017 | | 2017 |
